Close
4

Athena Athena

X

CAS 611-53-0 manufacturers and suppliers on PharmaCompass

PharmaCompass
  • Chemistry
CAS 611-53-0
Also known as: 611-53-0, Ibacitabine, 2'-deoxy-5-iodocytidine, 4-amino-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1h)-one, Ibacitabine [inn], Cytidine, 2'-deoxy-5-iodo-
Molecular Formula
C9H12IN3O4
Molecular Weight
353.11  g/mol
InChI Key
WEVJJMPVVFNAHZ-RRKCRQDMSA-N
FDA UNII
3EK8532DZV

Ibacitabine is an iodinated analog of deoxycytidine used topically in the treatment of herpes labialis.
1 2D Structure

CAS 611-53-0

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one
2.1.2 InChI
InChI=1S/C9H12IN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1
2.1.3 InChI Key
WEVJJMPVVFNAHZ-RRKCRQDMSA-N
2.1.4 Canonical SMILES
C1C(C(OC1N2C=C(C(=NC2=O)N)I)CO)O
2.1.5 Isomeric SMILES
C1[C@@H]([C@H](O[C@H]1N2C=C(C(=NC2=O)N)I)CO)O
2.2 Other Identifiers
2.2.1 UNII
3EK8532DZV
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2'-deoxy-5-iodocytidine

2. 5-iodo-2'-deoxycytidine, 125i-labeled

3. 5-iododeoxycytidine

4. Ibacitabine

5. Iododeoxycytidine

2.3.2 Depositor-Supplied Synonyms

1. 611-53-0

2. Ibacitabine

3. 2'-deoxy-5-iodocytidine

4. 4-amino-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1h)-one

5. Ibacitabine [inn]

6. Cytidine, 2'-deoxy-5-iodo-

7. Ai3-62629

8. Idc

9. 3ek8532dzv

10. Ibacitabine (inn)

11. Nsc-527083

12. Ibacitabinum [latin]

13. Ibacitabina [spanish]

14. Ibacitabina

15. Ibacitabinum

16. Mfcd00038063

17. Ccris 2826

18. Einecs 210-269-8

19. Nsc 527083

20. Unii-3ek8532dzv

21. Ibacitabin

22. 5-iodo-2\'-deoxycytidine

23. Ibacitabine [mart.]

24. Ibacitabine [who-dd]

25. Schembl225402

26. Chembl158653

27. 5-iodo-2'deoxycytidine

28. Chembl2104340

29. Amy8816

30. Dtxsid50209985

31. Chebi:135996

32. Bdbm50028585

33. Hg1100

34. Zinc17174212

35. Akos015853900

36. Akos015917916

37. Cs-w011854

38. Db13776

39. Hy-w011138

40. 4-amino-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodo-pyrimidin-2-one

41. Ds-14588

42. Db-008195

43. D07200

44. 611i530

45. A833066

46. Sr-01000945259

47. J-700095

48. Q5983577

49. Sr-01000945259-1

50. 5-iodo-2 Inverted Exclamation Marka-deoxycytidineai3-62629

51. 4-amino-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-iodo-1h-pyrimidin-2-one

52. 4-amino-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one; 5-idc;4-amino-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1h)-one

2.4 Create Date
2005-08-01
3 Chemical and Physical Properties
Molecular Weight 353.11 g/mol
Molecular Formula C9H12IN3O4
XLogP3-0.7
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass352.98725 g/mol
Monoisotopic Mass352.98725 g/mol
Topological Polar Surface Area108 Ų
Heavy Atom Count17
Formal Charge0
Complexity398
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)


4.2 ATC Code

D - Dermatologicals

D06 - Antibiotics and chemotherapeutics for dermatological use

D06B - Chemotherapeutics for topical use

D06BB - Antivirals

D06BB08 - Ibacitabine


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY